AstraZeneca Faces U.S. Suit Over Nexium Marketing
504230
A U.S. law firm has announced a class  action lawsuit against AstraZeneca Plc accusing the  Anglo-Swedish drugmaker of deception in its promotion of ulcer  pill Nexium.
432054
Mylan Pharmaceuticals vowed Monday to refile what it says will be a stronger federal complaint against the US Food and Drug Administration over a ruling that has forced the company to compete with so-called &quot;authorized generics.
148143
Johnson & Johnson JNJ.N has sued   Boston Scientific BSX.N and Abbott Laboratories Inc. ABT.N,   seeking at least $5.5 billion in damages related to J&J's   failed bid to acquire medical device maker Guidant Corp.
564304
WASHINGTON/LONDON  - An FDA review AstraZeneca  Plc's  under the name Coumadin.
211503
A lawsuit filed Monday attempts to recoup tens of millions spent by government-financed health programs to purchase the painkiller and to treat patients for its side effects.
156350
Drug maker AstraZeneca PLC reported Monday that the Food and Drug Administration approved its heartburn medication Nexium for the treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drugs, or NSAIDs.
408832
Swiss drugmaker Roche Holding AG is taking legal action against Israel's Teva Pharmaceutical Industries Ltd  in the United States to prevent Teva from selling a generic version of Roche osteoporosis drug Boniva, Roche said on Tuesday.
161543
Shares in pharmaceutical giants AstraZeneca PLC and GlaxoSmithKline PLC tumbled Friday after a US safety official raised concerns over key drugs sold by the companies.
578213
The world&#39;s largest computer software manufacturer filed suit Tuesday in US District Court against a local software retailer it claims is selling and distributing counterfeit software labels.
346497
An FDA review of AstraZeneca Plc&#39;s (AZN.L: Quote, Profile, Research) (AZN.N: Quote, Profile, Research) Exanta questioned the experimental drug&#39;s
39352
Wyeth  said on Monday it will  sue Teva Pharmaceuticals USA  for alleged patent  infringement and said it received an approvable letter from U.S  regulators for bazedoxifene, a drug that helps prevent  post-menopausal osteoporosis.
57856
The state and city of New York on Monday filed suit against Merck & Co. Inc., claiming the drugmaker concealed the risks of the withdrawn arthritis treatment Vioxx.
520469
GlaxoSmithKline Plc is facing a number of lawsuits from U.S. parents of children and adolescents given its antidepressant Paxil, following claims the company suppressed data showing the drug increased suicidal tendencies in young people.
291258
Merck &amp; Co., the drug maker defending about 27,000 lawsuits filed by users of the painkiller Vioxx, was accused in a Canadian lawsuit of failing to warn consumers its bone drug Fosamax may damage jaw bones, a law firm said.
7183
Johnson & Johnson JNJ.N is facing  a raft of lawsuits over a marketing campaign related to its  artificial sweetener Splenda, which accuse the company of  misleading buyers to believe Splenda is a natural product.
853
AstraZeneca, the troubled Anglo-Swedish drugs giant, is being urged by shareholders to waive a one million-pound (1.4 million-euro, 1.9 million-dollar) bonus being lined up for chief executive Tom McKillop following a string of company setbacks, a newspaper reported.
745195
A San Francisco law firm filed an antitrust lawsuit Thursday in state court against 15 of the biggest drugmakers, alleging they have conspired to charge &quot;artificially higher prices